Previous research indicates the potential utility of fatty acid-binding proteins (FABPs) as diagnostic biomarkers for various conditions, including cerebral infarction, Alzheimer’s disease, dementia with Lewy bodies, and Parkinson’s disease [1,2,3,4,5]. This evidence concerns the gene GOT2 and Parkinson disease.